These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 15358195

  • 1. Modulation of Janus kinase 2 by p53 in ovarian cancer cells.
    Reid T, Jin X, Song H, Tang HJ, Reynolds RK, Lin J.
    Biochem Biophys Res Commun; 2004 Aug 20; 321(2):441-7. PubMed ID: 15358195
    [Abstract] [Full Text] [Related]

  • 2. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
    Lin J, Jin X, Rothman K, Lin HJ, Tang H, Burke W.
    Cancer Res; 2002 Jan 15; 62(2):376-80. PubMed ID: 11809683
    [Abstract] [Full Text] [Related]

  • 3. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
    Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE, Arlinghaus RB.
    Oncogene; 2001 Sep 27; 20(43):6188-95. PubMed ID: 11593427
    [Abstract] [Full Text] [Related]

  • 4. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
    Lin J, Tang H, Jin X, Jia G, Hsieh JT.
    Oncogene; 2002 May 02; 21(19):3082-8. PubMed ID: 12082540
    [Abstract] [Full Text] [Related]

  • 5. Modulation of Janus kinase 2 by cisplatin in cancer cells.
    Song H, Sondak VK, Barber DL, Reid TJ, Lin J.
    Int J Oncol; 2004 Apr 02; 24(4):1017-26. PubMed ID: 15010843
    [Abstract] [Full Text] [Related]

  • 6. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM, Hawley TS, Hawley RG, Qu CK.
    Oncogene; 2003 Sep 04; 22(38):5995-6004. PubMed ID: 12955078
    [Abstract] [Full Text] [Related]

  • 7. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR, Welham MJ.
    Biochem J; 2002 Dec 15; 368(Pt 3):885-94. PubMed ID: 12220225
    [Abstract] [Full Text] [Related]

  • 8. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
    Huang JS, Guh JY, Hung WC, Yang ML, Lai YH, Chen HC, Chuang LY.
    Biochem J; 1999 Aug 15; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
    [Abstract] [Full Text] [Related]

  • 9. Regulation of cardiac Jak-2 in animal models of insulin resistance.
    Rojas FA, Carvalho CR, Paez-Espinosa V, Saad MJ.
    IUBMB Life; 2000 Jun 15; 49(6):501-9. PubMed ID: 11032244
    [Abstract] [Full Text] [Related]

  • 10. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J.
    Oncogene; 2001 Oct 04; 20(45):6643-50. PubMed ID: 11641791
    [Abstract] [Full Text] [Related]

  • 11. Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines.
    Rayanade RJ, Ndubuisi MI, Etlinger JD, Sehgal PB.
    J Immunol; 1998 Jul 01; 161(1):325-34. PubMed ID: 9647240
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
    Li H, Ahonen TJ, Alanen K, Xie J, LeBaron MJ, Pretlow TG, Ealley EL, Zhang Y, Nurmi M, Singh B, Martikainen PM, Nevalainen MT.
    Cancer Res; 2004 Jul 15; 64(14):4774-82. PubMed ID: 15256446
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
    Warnecke C, Kaup D, Marienfeld U, Poller W, Yankah C, Gräfe M, Fleck E, Regitz-Zagrosek V.
    J Mol Med (Berl); 2001 Sep 15; 79(9):510-21. PubMed ID: 11692164
    [Abstract] [Full Text] [Related]

  • 16. Jak2 tyrosine kinase mediates angiotensin II-dependent inactivation of ERK2 via induction of mitogen-activated protein kinase phosphatase 1.
    Sandberg EM, Ma X, VonDerLinden D, Godeny MD, Sayeski PP.
    J Biol Chem; 2004 Jan 16; 279(3):1956-67. PubMed ID: 14551204
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
    Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK, Lin J.
    Oncogene; 2001 Nov 29; 20(55):7925-34. PubMed ID: 11753675
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases.
    Cohen J, Altaratz H, Zick Y, Klingmüller U, Neumann D.
    Biochem J; 1997 Oct 15; 327 ( Pt 2)(Pt 2):391-7. PubMed ID: 9359406
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sodium orthovanadate suppresses palmitate-induced cardiomyocyte apoptosis by regulation of the JAK2/STAT3 signaling pathway.
    Liu J, Fu H, Chang F, Wang J, Zhang S, Caudle Y, Zhao J, Yin D.
    Apoptosis; 2016 May 15; 21(5):546-57. PubMed ID: 26921179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.